• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于杜氏利什曼原虫磷酸化聚糖发育和遗传研究的体外系统。

An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.

作者信息

Goyard Sophie, Segawa Hiroaki, Gordon Jennifer, Showalter Melissa, Duncan Robert, Turco Salvatore J, Beverley Stephen M

机构信息

Department of Molecular Microbiology, Washington University Medical School, Campus Box 8230, 660 S Euclid Ave, St. Louis, MO 63110, USA.

出版信息

Mol Biochem Parasitol. 2003 Aug 11;130(1):31-42. doi: 10.1016/s0166-6851(03)00142-7.

DOI:10.1016/s0166-6851(03)00142-7
PMID:14550894
Abstract

Glycoconjugates have been shown to play important roles in Leishmania development. However, the ability to study these molecules and other processes would benefit greatly from improved methods for genetic manipulation and analysis of the amastigote stage. This is especially challenging for L. donovani, the agent of the most severe form of leishmaniasis, which can rapidly lose virulence during in vitro culture. Here we report on a clonal subline of an L. donovani 1S2D (LdBob or LdB), which differentiates readily from promastigotes to amastigotes in axenic culture, and maintains this ability during extended parasite cultivation in vitro. This derivative can be plated and transfected efficiently while grown as promastigotes or amastigotes. Importantly, LdB maintains the ability to differentiate while undergoing genetic alterations required for creation of gene knockouts and complemented lines. Like virulent L. donovani, LdB exhibits down-regulation of lipophosphoglycan (LPG) synthesis and up-regulation of A2 protein synthesis in amastigotes. We showed that knockouts of LPG2, encoding a Golgi GDP-mannose transporter, eliminated phosphoglycan synthesis in LdB axenic amastigotes. These and other data suggest that LdB axenic amastigotes will be generally useful as a differentiation model in studies of gene expression, virulence, glycoconjugate function and drug susceptibility in L. donovani.

摘要

糖缀合物已被证明在利什曼原虫的发育中发挥重要作用。然而,研究这些分子和其他过程的能力将极大地受益于改进的利什曼原虫无鞭毛体阶段的基因操作和分析方法。对于杜氏利什曼原虫(最严重形式的利什曼病的病原体)来说,这尤其具有挑战性,因为它在体外培养过程中会迅速丧失毒力。在这里,我们报告了杜氏利什曼原虫1S2D(LdBob或LdB)的一个克隆亚系,它在无菌培养中很容易从前鞭毛体分化为无鞭毛体,并在体外长期培养寄生虫的过程中保持这种能力。这种衍生物在作为前鞭毛体或无鞭毛体生长时可以有效地铺板和转染。重要的是,LdB在进行基因敲除和互补系构建所需的基因改变时,仍保持分化能力。与有毒力的杜氏利什曼原虫一样,LdB在无鞭毛体中表现出脂磷壁酸(LPG)合成的下调和A2蛋白合成的上调。我们发现,编码高尔基体GDP-甘露糖转运蛋白的LPG2基因敲除消除了LdB无菌无鞭毛体中的磷酸聚糖合成。这些以及其他数据表明,LdB无菌无鞭毛体在杜氏利什曼原虫的基因表达、毒力、糖缀合物功能和药物敏感性研究中作为分化模型将具有普遍用途。

相似文献

1
An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.用于杜氏利什曼原虫磷酸化聚糖发育和遗传研究的体外系统。
Mol Biochem Parasitol. 2003 Aug 11;130(1):31-42. doi: 10.1016/s0166-6851(03)00142-7.
2
Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.缺乏高尔基体GDP-甘露糖转运蛋白LPG2的杜氏利什曼原虫在哺乳动物宿主中的毒力减弱。
Exp Parasitol. 2009 Jul;122(3):182-91. doi: 10.1016/j.exppara.2009.03.014. Epub 2009 Mar 27.
3
Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.杜氏利什曼原虫无共生体无鞭毛体中发育调控活性的表征
Mol Biochem Parasitol. 1998 Sep 1;95(1):9-20. doi: 10.1016/s0166-6851(98)00062-0.
4
Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.鉴定一种杜氏利什曼原虫的补偿性突变体(lpg2-REV),该突变体能够在巨噬细胞内作为无鞭毛体存活,且不依赖LPG2依赖性糖缀合物,及其对毒力和免疫策略的意义。
Infect Immun. 2004 Jun;72(6):3622-7. doi: 10.1128/IAI.72.6.3622-3627.2004.
5
The role of phosphoglycans in Leishmania-sand fly interactions.磷酸聚糖在利什曼原虫与白蛉相互作用中的作用。
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):406-11. doi: 10.1073/pnas.97.1.406.
6
Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.体外培养的杜氏利什曼原虫前鞭毛体中脂磷壁酸聚糖(LPG)和动基体膜蛋白(KMP)-11的表达降低。
J Parasitol. 1998 Jun;84(3):644-7.
7
Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.表达荧光素酶的杜氏利什曼原虫无鞭毛体的构建及其作为抗利什曼原虫化合物体外筛选的初步模型。
Curr Microbiol. 2012 Dec;65(6):696-700. doi: 10.1007/s00284-012-0209-1. Epub 2012 Sep 4.
8
Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability.利什曼原虫LPG3编码一种GRP94同源物,该同源物是磷酸聚糖合成所必需的,与寄生虫毒力有关,但与生存能力无关。
EMBO J. 2002 Sep 2;21(17):4458-69. doi: 10.1093/emboj/cdf447.
9
Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics.杜氏利什曼原虫无细胞内前鞭毛体的产生:其生长及生物学特性
Int J Parasitol. 2004 Feb;34(2):205-17. doi: 10.1016/j.ijpara.2003.10.011.
10
Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.杜氏利什曼原虫中一种无鞭毛体特异性蛋白A2缺失导致毒力丧失。
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8807-11. doi: 10.1073/pnas.94.16.8807.

引用本文的文献

1
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas disease.靶向赖氨酰-tRNA合成酶的抗锥虫喹唑啉类药物在急性恰加斯病小鼠模型中显示出部分疗效。
Sci Transl Med. 2025 Jul 9;17(806):eadu4564. doi: 10.1126/scitranslmed.adu4564.
2
Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis.鉴定杜氏利什曼原虫和婴儿利什曼原虫恰加斯亚种(新旧世界内脏利什曼病的病原体)的强效抑制剂。
Commun Biol. 2025 Jul 8;8(1):1021. doi: 10.1038/s42003-025-08386-0.
3
Putrescine Depletion in Parasites Causes Immediate Proliferation Arrest Followed by an Apoptosis-like Cell Death.
寄生虫中腐胺的消耗会导致其立即停止增殖,随后发生类似凋亡的细胞死亡。
Pathogens. 2025 Feb 2;14(2):137. doi: 10.3390/pathogens14020137.
4
Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic Agents.取代4-氨基噌啉作为广谱抗寄生虫药物的鉴定
ACS Infect Dis. 2025 Mar 14;11(3):584-599. doi: 10.1021/acsinfecdis.4c00666. Epub 2025 Feb 12.
5
Type 1 diabetes and parasite infection: An exploratory study in NOD mice.1 型糖尿病与寄生虫感染:NOD 小鼠的探索性研究。
PLoS One. 2024 Oct 22;19(10):e0308868. doi: 10.1371/journal.pone.0308868. eCollection 2024.
6
Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1.利什曼原虫中的甾醇 14-α 脱甲基酶(CYP51)的活性可能依赖于细胞色素 P450 还原酶 1。
PLoS Pathog. 2024 Jul 11;20(7):e1012382. doi: 10.1371/journal.ppat.1012382. eCollection 2024 Jul.
7
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc.DNDI-6174 是一种针对细胞色素 bc 的内脏利什曼病的临床前候选药物。
Sci Transl Med. 2023 Dec 13;15(726):eadh9902. doi: 10.1126/scitranslmed.adh9902.
8
Antimony resistance and gene expression in : spotlight on molecular and proteomic aspects.抗锑性与 : 分子和蛋白质组学方面的基因表达研究焦点。
Parasitology. 2024 Jan;151(1):1-14. doi: 10.1017/S0031182023001129. Epub 2023 Nov 28.
9
Quinolone-3-amidoalkanol: A New Class of Potent and Broad-Spectrum Antimicrobial Agent.喹诺酮-3-酰胺醇:一类新型强效广谱抗菌剂。
ACS Omega. 2023 May 4;8(19):17086-17102. doi: 10.1021/acsomega.3c01406. eCollection 2023 May 16.
10
Antileishmanial Activities of ()-2-(Nitroimidazolylmethylene)-3()-Benzofuranones: Synthesis, Assessment, and Bioactivation by NTR 1 and 2.()-2-(硝基咪唑基亚甲基)-3-(苯并呋喃酮)的抗利什曼原虫活性:合成、评估和 NTR1 和 NTR2 的生物激活作用。
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0058322. doi: 10.1128/aac.00583-22. Epub 2022 Oct 26.